BUMA PHARMA

Antwerpen ·KBO/BCE: BE 0803.488.513

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	30-08-2025	30 d late	2025-00476101
31-12-2023	31-07-2024	30-08-2024	30 d late	2024-00453593

Metric	This company	Sector median	Position in the sector
Solvency	59.5%	20.4%	better than 82% of 6697 sector peers
Net result	€15k	€4k	better than 70% of 6677 sector peers
Equity	€25k	€16k	better than 58% of 6711 sector peers
Gross operating margin	€23k	€24k	better than 49% of 6656 sector peers
Total assets	€41k	€94k	better than 27% of 6701 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€41k
Fixed assets	21/28	€3k
Tangible fixed assets	22/27	€3k
Current assets	29/58	€38k
Cash & bank	54/58	€38k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€41k
Equity	10/15	€25k
Contributions / capital	10/11	€1k
Reserves	13	€24k
Amounts payable	17/49	€17k
Amounts payable within one year	42/48	€17k
Trade debts payable within one year	44	€622
Income statement
Gross operating margin	9900	€23k
Operating result	9901	€22k
Financial charges	65	€132
Result before taxes	9903	€22k
Income taxes	67/77	€6k
Net result for the period	9904	€15k
Result to be appropriated	9905	€15k

Summary